section name header

Introduction

After a fibrin clot has formed, the fibrinolytic system acts to prevent excessive clotting. In this system, plasmin digests fibrin. Fibrinogen also may be degraded if there is a disproportion among plasmin, fibrin, and fibrinogen. The substances that result from this degradation—fibrin split products (FSP) or fibrinogen degradation products (FDP)—interfere with normal coagulation and with formation of the hemostatic platelet plug.

Normally, FSP are removed from the circulation by the liver and the reticuloendothelial system. In situations such as widespread bleeding or DIC, however, FSP are found in the serum.

Tests for FSP are performed on serum using immunologic techniques. Because FSP do not coagulate, they remain in the serum after fibrinogen is removed through clot formation. Antifibrinogen antibodies are added to the serum to detect the presence of FSP. Because normal serum contains neither FSP nor fibrinogen, there should be nothing present to react with the antibodies. If a reaction occurs, FSP are present.35

Reference Values

Interfering Factors

Indications

Care Before Procedure

Nursing Care Before the Procedure

Client preparation is the same as that for any study involving the collection of a peripheral blood sample (see Appendix I).

Procedure

A venipuncture is performed and the sample collected in a red-topped tube or in a special tube provided for the FSP test by the laboratory. As with other coagulation studies, traumatic venipunctures and excessive agitation of the sample should be avoided. The sample should be sent to the laboratory promptly.

Care After Procedure

Nursing Care After the Procedure

Care and assessment after the procedure are essentially the same as for any study involving the collection of a peripheral blood sample.